| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 266.732 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 278.578 | 87 |
| GSM780709 | Untreated after 4 days (C3_1) | 261.508 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 276.465 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 296.371 | 87 |
| GSM780721 | Untreated after 4 days (C3_2) | 248.545 | 86 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 277.895 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 258.874 | 86 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 231.771 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 287.854 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 262.598 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 245.275 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 249.778 | 86 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 274.508 | 87 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 248.865 | 86 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 252.774 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 283.386 | 87 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 250.973 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 250.924 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 247.56 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 259.209 | 86 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 263.486 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 259.99 | 86 |